Bringing in health technology assessment and cost-effectiveness considerations at an early stage of drug development
about
Industry Perspectives on Market Access of Innovative Drugs: The Relevance for Oncology DrugsEmerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the LiteratureTrends in clinical development timeframes for antiviral drugs launched in the UK, 1981-2014: a retrospective observational study.Next-generation multiple myeloma treatment: a pharmacoeconomic perspective.
P2860
Bringing in health technology assessment and cost-effectiveness considerations at an early stage of drug development
description
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Bringing in health technology ...... arly stage of drug development
@ast
Bringing in health technology ...... arly stage of drug development
@en
Bringing in health technology ...... arly stage of drug development
@nl
type
label
Bringing in health technology ...... arly stage of drug development
@ast
Bringing in health technology ...... arly stage of drug development
@en
Bringing in health technology ...... arly stage of drug development
@nl
prefLabel
Bringing in health technology ...... arly stage of drug development
@ast
Bringing in health technology ...... arly stage of drug development
@en
Bringing in health technology ...... arly stage of drug development
@nl
P2860
P1433
P1476
Bringing in health technology ...... arly stage of drug development
@en
P2093
Bengt Jönsson
P2860
P304
P356
10.1016/J.MOLONC.2014.10.009
P407
P577
2014-10-23T00:00:00Z